Top compounds associated with response to GYPC

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	vorinostat:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.017	0.7
mRNA	erlotinib:PLX-4032 (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.018	0.7
mRNA	BRD-K85133207	CTRPv2	pan-cancer	AAC	0.018	0.7
mRNA	Erlotinib	UHNBreast	pan-cancer	AAC	-0.12	0.7
mRNA	BRD-K79669418	CTRPv2	pan-cancer	AAC	-0.025	0.7
mRNA	istradefylline	CTRPv2	pan-cancer	AAC	-0.027	0.7
mRNA	Tipifarnib	FIMM	pan-cancer	AAC	0.079	0.7
mRNA	RG-108	CTRPv2	pan-cancer	AAC	0.017	0.7
mRNA	navitoclax:piperlongumine (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.017	0.7
mRNA	dexamethasone	CTRPv2	pan-cancer	AAC	-0.016	0.7

Download CSV